C49.2

Clinical Causes: Genetic factors that predispose individuals to soft tissue cancers Previous radiation therapy to the area History of certain chemical exposures or carcinogens Pre-existing benign soft tissue tumors that may transform malignant Underlying genetic syndromes such as Li-Fraumeni syndrome or Gardner syndrome

Key Symptoms: A noticeable lump or mass in the affected limb, often painless in early stages Pain or discomfort in the area, especially as the tumor grows Swelling or inflammation around the tumor site Limited movement or functional impairment in the limb due to tumor size or location Weight loss, fatigue, or general malaise in advanced cases

Diagnosis Path: Diagnosing a malignant neoplasm of the connective and soft tissue involves several steps: - Physical examination to assess the lump or mass - Imaging tests such as MRI, CT scans, or ultrasound to evaluate the size, location, and extent of the tumor - Biopsy to obtain a tissue sample for microscopic analysis and confirmation of malignancy - Additional tests may include blood work and scans to check for metastasis or spread to other parts of the body

Treatment Protocols: Treatment strategies depend on the tumor’s size, location, and stage. Common approaches include: - Surgical removal of the tumor, often aiming for complete excision with clear margins - Radiotherapy to shrink the tumor before surgery or destroy residual cancer cells afterward - Chemotherapy may be considered, especially if the tumor has spread or is high-grade - Targeted therapies or immunotherapy could be options based on specific tumor characteristics - Rehabilitation and physical therapy post-treatment to restore limb function and mobility Early diagnosis and multidisciplinary care are vital for improving outcomes and maintaining quality of life for affected individuals.